Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice
Open accessThe DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Abstract
Although elevated activity of the tryptophan-degrading enzyme indoleamine 2,3-dioxygenase (IDO) has been proposed to mediate comorbid depression in inflammatory disorders, its causative role has never been tested. We report that peripheral administration of lipopolysaccharide (LPS) activates IDO and culminates in a distinct depressive-like behavioral syndrome, measured by increased duration of immobility in both the forced-swim and tail suspension tests. Blockade of IDO activation either indirectly with the anti-inflammatory tetracycline derivative minocycline, that attenuates LPS-induced expression of proinflammatory cytokines, or directly with the IDO antagonist 1-methyltryptophan (1-MT), prevents development of depressive-like behavior. Both minocycline and 1-MT normalize the kynurenine/tryptophan ratio in the plasma and brain of LPS-treated mice without changing the LPS-induced increase in turnover of brain serotonin. Administration of L-kynurenine, a metabolite of tryptophan that is generated by IDO, to naive mice dose dependently induces depressive-like behavior. These results implicate IDO as a critical molecular mediator of inflammation-induced depressive-like behavior, probably through the catabolism of tryptophan along the kynurenine pathway.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“depressive-like behaviors in rodents are mediated by an enzyme that degrades tryptophan, called indoleamine 2,3dioxygenase (IDO; O'Connor et al., 2009; see also Maes et al., 2011)”
From From stress to inflammation and major depressive disorder: A social signal transduction theory of depression. (2014) · cites this paper as O'Connor et al., 2009
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Animal studies have shown that inflammation promotes a pattern of behavior known as sickness behavior that includes symptoms of depression, such as fatigue, anhedonia, and social withdrawal.[10,11]”
From SUICIDAL IDEATION IS ASSOCIATED WITH ELEVATED INFLAMMATION IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER: Research Article: Suicidal Ideation and Inflammation (2013) · cites this paper as [10]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Interestingly, blocking glutamate receptors with ketamine or inhibiting IDO activity protects mice from LPS- or stress-induced depressive-like behaviour but leaves the inflammatory response intact85,86.”
From The role of inflammation in depression: from evolutionary imperative to modern treatment target (2016) · cites this paper as [86]
Experimental — accuracy not yet measuredIn the citing paper
“In preclinical models, LPS-induced depressive behavior is mediated by IDO activation (O’Connor et al., 2009).”
From The role of inflammation in core features of depression: Insights from paradigms using exogenously-induced inflammation. (2018) · cites this paper as O’Connor et al., 2009
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
Lang, U. E., & Borgwardt, S. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350094 · Cited by 8,475
From inflammation to sickness and depression: when the immune system subjugates the brain
Dantzer, R., O'Connor, J. C., Freund, G. G., Johnson, R. W., & Kelley, K. W. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2297 · Cited by 7,395
Self-citationPrevention of Allogeneic Fetal Rejection by Tryptophan Catabolism
Munn, D. H., Zhou, M., Attwood, J. T., Bondarev, I., Conway, S. J., Marshall, B., Brown, C., & Mellor, A. L. (1998) · Science · doi:10.1126/science.281.5380.1191 · Cited by 2,585
Ido expression by dendritic cells: tolerance and tryptophan catabolism
Mellor, A. L., & Munn, D. H. (2004) · Nature Reviews Immunology · doi:10.1038/nri1457 · Cited by 2,341
Uyttenhove, C., Pilotte, L., Théate, I., Stroobant, V., Colau, D., Parmentier, N., Boon, T., & Van den Eynde, B. J. (2003) · Nature Medicine · doi:10.1038/nm934 · Cited by 2,305
Mood disorders in the medically ill: scientific review and recommendations
Evans, D. L., Charney, D. S., Lewis, L., Golden, R. N., Gorman, J. M., Krishnan, K. R. R., Nemeroff, C. B., Bremner, J. D., Carney, R. M., Coyne, J. C., et al. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.05.001 · Cited by 1,071
Zhu, S., Stavrovskaya, I. G., Drozda, M., Kim, B. Y. S., Ona, V., Li, M., Sarang, S., Liu, A. S., Hartley, D. M., Wu, D. C., et al. (2002) · Nature · doi:10.1038/417074a · Cited by 1,067
Potential Regulatory Function of Human Dendritic Cells Expressing Indoleamine 2,3-Dioxygenase
Munn, D. H., Sharma, M. D., Lee, J. R., Jhaver, K. G., Johnson, T. S., Keskin, D. B., Marshall, B., Chandler, P., Antonia, S. J., Burgess, R., et al. (2002) · Science · doi:10.1126/science.1073514 · Cited by 1,028
Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia
Yrjänheikki, J., Keinänen, R., Pellikka, M., Hökfelt, T., & Koistinaho, J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15769 · Cited by 1,006
Cytokine-induced sickness behaviour: mechanisms and implications
Konsman, J. P., Parnet, P., & Dantzer, R. (2002) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)02088-9 · Cited by 999
Self-citation
Cited by
Items 901–1,000 of 1,001
White, K. A., Hutton, S. R., Weimer, J. M., & Sheridan, P. A. (2016) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2016.06.007 · Cited by 14
Proceeding of the 8th Alcohol Hangover Research Group Meeting
Mackus, M., Adams, S. H., Barzilay, A., Benson, S., Blau, L. E., Iversen, J. M., Johnson, S. J., Keshavarzian, A., Scholey, A. B., Smith, G. S., et al. (2017) · Current Drug Abuse Reviews · doi:10.2174/1874473709666161229121527 · Cited by 14
“Studies have shown that a propensity to alcoholism and several other mental disorders are linked to dopamine D2 and serotonin pathways [25].”
Kitamura, Y., Hongo, S., Yamashita, Y., Yagi, S., Otsuki, K., Miki, A., Okada, A., Ushio, S., Esumi, S., & Sendo, T. (2018) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2018.10.049 · Cited by 14
Kim, N., Martínez, C. C., Jang, D. S., Lee, J. K., & Oh, M. S. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.01.017 · Cited by 12
Yang, E., Kim, J. Y., Yang, S. H., Lee, E., Sun, W., Lee, H. W., & Kim, H. (2019) · Experimental Neurobiology · doi:10.5607/en.2019.28.6.709 · Cited by 12
“The LPS dose was based on a previously reported study [19].”
BackgroundMethodBumetanide prevents diazepam-modified anxiety-like behavior in lipopolysaccharide-treated mice
Matsumoto, D., Ushio, S., Wada, Y., Noda, Y., Esumi, S., Izushi, Y., Kitamura, Y., & Sendo, T. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.174195 · Cited by 15
Baumann, K. K., Liang, W. S., Quaranta, D. V., Wilson, M., Asrat, H. S., Thysell, J. A., Sarchi, A. V., Banks, W. A., & Erickson, M. A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24021612 · Cited by 13
“The activation of IDO has been shown to mediate depressive-like behaviors following inflammatory stimuli [28,29], and kynurenine elevations have been implicated in depression [30] and in other neurological diseases [31].”
BackgroundInfluentialKYNURENINES IN PATHOGENESIS OF ENDOGENOUS PSYCHIATRIC DISORDERS
Shilov, Y., & Mv, B. (2013) · Annals of the Russian academy of medical sciences · doi:10.15690/vramn.v68i1.535 · Cited by 17
Neuronal and Non-Neuronal GABA in COVID-19: Relevance for Psychiatry
Sfera, A., Thomas, K. G., Sasannia, S., Anton, J. J., Andronescu, C. V., Garcia, M., Sfera, D. O., Cummings, M. A., & Kozlakidis, Z. (2022) · Reports — Medical Cases Images and Videos · doi:10.3390/reports5020022 · Cited by 11
“Interestingly, ANG II upregulates TLR4, the main LPS sensor, augmenting inflammation and neuropsychiatric pathology [43,66–68].”
Xu, Q., Liu, X., Heng, H., Wang, H., Chen, K., Chan, E. W., Yang, G., & Chen, S. (2025) · PLoS Pathogens · doi:10.1371/journal.ppat.1012979 · Cited by 13
“In contrast, Ido1 knockout mice do not display these behaviors [57,58].”
O’Regan, G., Plummer, Z., Christie, B. R., Shultz, S. R., & Allen, J. (2026) · Journal of Neuroinflammation · doi:10.1186/s12974-026-03717-2 · Cited by 15
“It was found that male mice were protected from the depressogenic effects of centrally or peripherally administered lipopolysaccharide (LPS) when IDO activity was inhibited through pharmacological or genetic manipulation [113, 114].”
Prenatal fluoxetine exposure affects cytokine and behavioral response to an immune challenge
Avitsur, R., Levy, S., Grinshpahet, R., Goren, N., Hirsh, O., & Zalko, A. (2015) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2015.05.006 · Cited by 11
“Main effects of thepostnatal treatmentwill not bediscussed as our data replicatesfindings that were previously reported in numerous papers (e.g., Avitsur and Yirmiya, 1999; Avitsur and Sheridan, 2009; O'Connor et al., 2009; Dantzer et al., 2011).”
BackgroundToo, L. K., McQuillan, J. A., Ball, H. J., Kanai, M., Nakamura, T., Funakoshi, H., McGregor, I. S., & Hunt, N. H. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.05.018 · Cited by 12
Thymelaea genus: Ethnopharmacology, Chemodiversity, and Bioactivities
Marmouzi, I., Bouchmaa, N., Kharbach, M., Ezzat, S. M., Merghany, R. M., Berkiks, I., & Jemli, M. E. (2021) · South African Journal of Botany · doi:10.1016/j.sajb.2021.06.014 · Cited by 11
Tomita, K., Yamanishi, S., Igarashi, K., Oogai, Y., Kuwahara, Y., Roudkenar, M. H., Roushandeh, A. M., Miyawaki, S., Kurimasa, A., & Sato, T. (2021) · Peptides · doi:10.1016/j.peptides.2021.170734 · Cited by 11
LPS-induced impairment of Na+/K+-ATPase activity: ameliorative effect of tannic acid in mice
Luduvico, K. P., Spohr, L., Soares, M. S. P., Teixeira, F. C., Bona, N. P., de Mello, J. E., Spanevello, R. M., & Stefanello, F. M. (2022) · Metabolic Brain Disease · doi:10.1007/s11011-022-01036-y · Cited by 13
Arshad, H. M., Ahmad, F.-U.-D., & Lodhi, A. H. (2022) · Drug Design Development and Therapy · doi:10.2147/dddt.s383054 · Cited by 14
“kynurenine pathway; tryptophan, the principal amino acid constituent of serotonin, is depleted, and neuro-modulators (serotonergic metabolites) are produced which can modify the dopamine and glutamate control via regulating the serotonin receptors.(7) Inflammatory mediators strongly affects the cholinergic pathway sit…”
BackgroundTejkalová, H., Jakob, L., Kvasnová, S., Klaschka, J., Sechovcová, H., Mrázek, J., Páleníček, T., & Fliegerova, K. O. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e15417 · Cited by 13
Increased symptoms of illness following prenatal stress: Can it be prevented by fluoxetine?
Avitsur, R. (2016) · Behavioural Brain Research · doi:10.1016/j.bbr.2016.09.021 · Cited by 11
Liu, Y., Zhao, L., Zhou, M., Wang, H., Yang, N., & Dai, S.-S. (2019) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2019.01.022 · Cited by 12
Koga, M., Toda, H., Kinoshita, M., Asai, F., Nagamine, M., Shimizu, K., Kobayashi, Y., Morimoto, Y., & Yoshino, A. (2020) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.109978 · Cited by 12
Neurological Infection, Kynurenine Pathway, and Parasitic Infection by Neospora caninum
Del’Arco, A. E., Argolo, D. S., Guillemin, G. J., Costa, M. D. F. D., Costa, S. L., & Pinheiro, A. M. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2021.714248 · Cited by 13
“Similarly, we have found in mixed cultures of astrocytes and microglia that N. caninum induces the production of TNF-a, IL-10, IL-6, and nitric oxide (NO) (55, 73–75).”
BackgroundInfluentialLi, X., Peng, Z., Jiang, L., Zhang, P., Yang, P., Yuan, Z., & Cheng, J. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1124845 · Cited by 14
“Furthermore, cytokine levels in the brain that were significantly elevated in mice exposed to LPS showed comparable levels in mice with and without CRS exposure.”
MethodInfluentialDaniels, S., Horman, T., Lapointe, T., Melanson, B. A., Storace, A., Kennedy, S. H., Frey, B. N., Rizvi, S. J., Hassel, S., Müller, D. J., et al. (2019) · Journal of Affective Disorders · doi:10.1016/j.jad.2019.11.108 · Cited by 12
University of Veterinary Medicine Hannover
Komm, K. (2010) · Cited by 11
Xue, T., Zhou, Y., Wang, Z., Wang, L., Xia, T., Yan, M., & Chang, Q. (2024) · Behavioural Brain Research · doi:10.1016/j.bbr.2024.115142 · Cited by 11
Alzarea, S. I., & Rahman, S. (2024) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/0118715273311527240916050749 · Cited by 10
Weidenfors, J. A., Griška, V., Li, X., Pranckevičienė, A., Pakalnienė, J., Atlas, A., Franzén‐Röhl, E., Piehl, F., Lindquist, L., Mickienė, A., et al. (2025) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2025.02.005 · Cited by 10
Molecular mechanisms and clinical value of the correlation between depression and cancer
Chen, Y., Lu, Y.-F., Chen, S., Liu, P., He, J., Jiang, L., & Zhang, J. (2025) · Medical Oncology · doi:10.1007/s12032-025-02763-9 · Cited by 14
“This mechanism is also considered important in cytokine-induced depression [127, 128].”
Mo, X., Guo, S., He, D., Cheng, Q., Yang, Y., Wang, H., Ren, Y., Liu, L., & Xie, P. (2025) · Gut Pathogens · doi:10.1186/s13099-025-00739-8 · Cited by 10
McColgan, L., McNaugher, G. A., Church, M., Murray, E. K., Kelly, C., Coyle, S., & McGilligan, V. (2026) · Psychiatry Research · doi:10.1016/j.psychres.2026.117003 · Cited by 11
Mu, J., Liu, X., Dong, Y.-H., Fang, Y.-Y., Qiu, S.-D., Zhang, F., & Liu, K. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.998397 · Cited by 11
“Previous studies identified IDO-1 as a critical modulator of depressionand anxiety-like behaviors induced by systemic inflammation (38, 39).”
BackgroundWu, W., Zhong, W., Lin, Z., & Yan, J. (2023) · Clinical and Experimental Nephrology · doi:10.1007/s10157-023-02332-2 · Cited by 10
“Previous studies have shown that IDO is induced to express in a cellular infection model, especially in response to interferon-gamma or lipopolysaccharide signaling [14, 15], and plays an important role in immune regulation through TLR4 [16, 17].”
BackgroundNagasawa, M., Otsuka, T., Ogino, Y., Yoshida, J., Tomonaga, S., Yasuo, S., & Furuse, M. (2013) · Acta Neuropsychiatrica · doi:10.1017/neu.2013.56 · Cited by 9
“However, it is reported that kynurenine administration induces depression-like behaviours in mice (46).”
BackgroundNowacka-Chmielewska, M. M., Liśkiewicz, D., Paul-Samojedny, M., Bielecka, A., Barski, J. J., Małecki, A., & Obuchowicz, E. (2017) · Pharmacological Reports · doi:10.1016/j.pharep.2017.01.004 · Cited by 10
Sialylated N-glycan profile during acute and chronic infections with Toxoplasma gondii in mice
Rehan, I. F., Mahmoud, M. E., Salman, D., Elnagar, A., Salman, S., Youssef, M., Aziz, A. R. A., Bazh, E. K., & Hesham, A. E. (2020) · Scientific Reports · doi:10.1038/s41598-020-60681-4 · Cited by 11
Fluoxetine triggers selective apoptosis in inflammation‐induced proliferating (Ki‐67high) thymocytes
Ghosh, S., Choudhury, S., Mukherjee, S., Gupta, P., Chowdhury, O., Baral, R., & Chattopadhyay, S. (2018) · Immunology and Cell Biology · doi:10.1111/imcb.12227 · Cited by 10
“Moreover, fluoxetine supplementation could reduce both nuclear and cytosolic expression of p53 as explained previously.(42) The decrease in p53 nuclear expression in fluoxetine-supplemented groups in the siRNA-transfected”
BackgroundComprehensive behavioral analysis of indoleamine 2,3‐dioxygenase knockout mice
Hirata, N., Hattori, S., Shoji, H., Funakoshi, H., & Miyakawa, T. (2018) · Neuropsychopharmacology Reports · doi:10.1002/npr2.12019 · Cited by 10
Wang, L., Li, H., Zhao, Y., Sun, X., Qian, M., Shao, F., Lin, L., Hu, W., Dai, L., & Bao, H. (2025) · Phytotherapy Research · doi:10.1002/ptr.70106 · Cited by 10
Inflammation as a mediator of stress-related psychiatric disorders
Flux, M. C., & Lowry, C. A. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-85654-6.00052-6 · Cited by 15
Mamunur, R., Hashioka, S., Azis, I. A., Jaya, M. A., JERIN, S. J. F., Kimura‐Kataoka, K., Fujihara, J., Inoue, K., Inagaki, M., & Takeshita, H. (2023) · Journal of Integrative Neuroscience · doi:10.31083/j.jin2205120 · Cited by 9
“Several animal studies have demonstrated that peripheral administration of lipopolysaccharide (LPS) from Escherichia coli increases the levels of pro-inflammatory cytokines in both the periphery and brain and induces abnormal behavior similar to MD, called depressive-like behavior [14–17].”
BackgroundNeural Network Excitation/Inhibition: A Key to Empathy and Empathy Impairment
Tang, Y., Wang, C., Li, Q., Liu, G., Song, D. F., Quan, Z., Yan, Y., & Qing, H. (2024) · The Neuroscientist · doi:10.1177/10738584231223119 · Cited by 9
“In an animal model of depression, lipopolysaccharide provoked robust microglial activation and cytokine secretion and induced depression-like symptoms (O’Connor and others 2009).”
miR-143-3p modulates depressive-like behaviors via Lasp1 in the mouse ventral hippocampus
Yu, H., Li, X., Zhang, Q., Geng, L., Su, B., & Wang, Y. (2024) · Communications Biology · doi:10.1038/s42003-024-06639-y · Cited by 12
“TST was assessed for depressive-like behavior based on a previous report 44 .”
MethodInfluentialDepression, Inflammation and Tryptophan Metabolism
McCusker, R. H., Kavelaars, A., Heijnen, C. J., Dantzer, R., & Kelley, K. W. (2013) · Wiley eBooks · doi:10.1002/9781118314814.ch23 · Cited by 13
Self-citationYu, X., Luo, J., Chen, L., Zhang, C., Zhang, R., Hu, Q., Qiao, S., & Li, L. (2015) · RSC Advances · doi:10.1039/c5ra10668k · Cited by 9
Circadian arrhythmia dysregulates emotional behaviors in aged Siberian hamsters
Prendergast, B. J., Onishi, K. G., Patel, P. N., & Stevenson, T. J. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2013.12.010 · Cited by 10
Reduction of hippocampal IL-6 levels in LPS-injected rats following acute exendin-4 treatment
Géa, L. P., da Rosa, E. D., Panizzutti, B., de Aguiar, É. Z., de Oliveira, L. F., Ferrari, P., Piato, Â., Gomez, R., Colombo, R., & Rosa, A. R. (2020) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-020-01867-5 · Cited by 10
de Arruda, C. M., Doneda, D. L., de Oliveira, V. V., da Silva, R. A. L., de Matos, Y. A. V., Fernandes, I. L., Rohden, C. A. H., Viola, G. G., Rios-Santos, F., de Lima, E., et al. (2022) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2022.173433 · Cited by 9
Moreira, L. K. D. S., Turones, L. C., Campos, H. M., Martins, A. N., Thomaz, D. V., Gil, E. D. S., Ghedini, P. C., da Rocha, F. F., Menegatti, R., Fajemiroye, J. O., et al. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.121199 · Cited by 9
Lipopolysaccharide‐induced sickness behavior is not altered in male Fmr1 ‐deficient mice
Santana‐Coelho, D., Hodges, S. L., Quintero, S. I., Womble, P. D., Sullens, D. G., Narvaiz, D. A., Herrera, R., Sekeres, M. J., & Lugo, J. N. (2023) · Brain and Behavior · doi:10.1002/brb3.3142 · Cited by 9
Deyama, S., Sugie, R., Tabata, M., & Kaneda, K. (2023) · Nutritional Neuroscience · doi:10.1080/1028415x.2023.2254542 · Cited by 9
Dong, B., Wang, J., Wang, M., Chen, Q., Kong, X., Chang, J., Li, X., Yue, T., & Wang, Y. (2023) · Talanta · doi:10.1016/j.talanta.2023.125272 · Cited by 9
de Oliveira, C. M., Morael, J., Guille, A., Amadieu, C., Vancassel, S., Gaudout, D., Capuron, L., Pourtau, L., & Castanon, N. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1267839 · Cited by 13
Self-citationEnko, D., Zelzer, S., Wenninger, J., Holasek, S. J., Schnedl, W. J., Baranyi, A., Herrmann, M., & Meinitzer, A. (2020) · EXCLI journal · doi:10.17179/excli2020-2940 · Cited by 10
“LPS is known to induce IDO expression, the key enzyme of TRP catabolism, in an INF-γ-independent way (Wang et al., 2010; O’Connor et al., 2009).”
BackgroundDomingues, M., Casaril, A. M., Smaniotto, T. Â., Birmann, P. T., Lourenço, D. D. A., Bampi, S. R., Vieira, B. M., Lenardao, E. J., & Savegnago, L. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.174570 · Cited by 9
Tracking TRYCAT: A Critical Appraisal of Kynurenine Pathway Quantifications in Blood
Coppens, V., Verkerk, R. M., & Morrens, M. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.825948 · Cited by 9
“), or clinical trials with compounds known to mediate the KP in animal research or other human pathologies such as IDO or KMO inhibitors (O’Connor et al., 2009; Prendergast et al., 2018; Réus et al., 2018).”
BackgroundChen, X., Zhu, M., Shi, Q., Huang, Z., Zhu, J., Sun, P., Zhang, H., Yang, L., Chen, X., Zhang, Y., et al. (2025) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2025.117597 · Cited by 8
Unveiling tryptophan dynamics and functions across model organisms via quantitative imaging
Wang, K., Chen, T.-L., Zhang, X., Cao, J., Wang, P., Wang, M., Du, J., Mu, Y., & Tao, R. (2024) · BMC Biology · doi:10.1186/s12915-024-02058-x · Cited by 10
“These results align with the elevated serotonin concentration in the brain and fatigue and depression behaviors in LPS-treated mice [29] and patients with inflammation symptoms, suggesting a potential metabolic link between immune response and animal behavior [1].”
Fang, R.-Y., Pan, X.-R., Zeng, X.-X., Li, Z., Chen, B.-F., Zeng, H.-M., & Peng, J. (2024) · World Journal of Psychiatry · doi:10.5498/wjp.v15.i1.101134 · Cited by 10
Turk, B. R., Gschwandtner, M. E., Mauerhofer, M., & Löffler‐Stastka, H. (2015) · Medicine · doi:10.1097/md.0000000000000743 · Cited by 10
Notarangelo, F. M., & Schwarcz, R. M. (2021) · European Journal of Neuroscience · doi:10.1111/ejn.15416 · Cited by 9
Veit, C., Foister, S., Valros, A., Munsterhjelm, C., Sandercock, D. A., Janczak, A. M., Ranheim, B., & Nordgreen, J. (2021) · animal · doi:10.1016/j.animal.2021.100332 · Cited by 8
Pathogenesis and management of fatigue in primary biliary cholangitis
Shamshtein, D., & Liwinski, T. (2022) · Fatigue Biomedicine Health & Behavior · doi:10.1080/21641846.2022.2034473 · Cited by 10
Alzarea, S. I., Alhassan, H. H., Alzarea, A. I., Al‐Oanzi, Z. H., & Afzal, M. (2022) · Brain Sciences · doi:10.3390/brainsci12050655 · Cited by 8
Dietary Hesperidin Suppresses Lipopolysaccharide-Induced Inflammation in Male Mice
Sato, M., Okuno, A., Ishisono, K., Yajima, Y., & Toyoda, A. (2022) · International Journal of Tryptophan Research · doi:10.1177/11786469221128697 · Cited by 9
Zheng, Y., Tufvesson‐Alm, M., Trepci, A., Imbeault, S., Li, X., Schwieler, L., Engberg, G., & Erhardt, S. (2023) · Acta Neuropsychiatrica · doi:10.1017/neu.2023.40 · Cited by 8
“…., 2020; Mao et al ., 2021) and activate the kynurenine pathway following induction of indoleamine 2,3-dioxygenase (IDO), but with differential downstream metabolite profiles (O ’ Connor et al ., 2009; Larsson et al ., 2016; Parrott et al ., 2016a; Parrott et al ., 2016b; Imbeault et al ., 2020).”
InfluentialEkici, M., Güngör, H., & Mert, D. (2023) · Journal of the Hellenic Veterinary Medical Society · doi:10.12681/jhvms.30232 · Cited by 8
Study on anti-inflammatory and immunomodulatory effects of fluoxetine in rat models of inflammation
Kostadinov, I., Delev, D. P., Petrova, A., Stanimirova, I., Draganova, K., Kružliak, P., Kostadinova, I. I., & Murdjeva, M. (2015) · European Journal of Inflammation · doi:10.1177/1721727x15618671 · Cited by 8
The Contribution of Adult Hippocampal Neurogenesis to the Progression of Psychiatric Disorders
Kohman, R. A., & Rhodes, J. S. (2017) · Modern trends in psychiatry · doi:10.1159/000470812 · Cited by 8
Unteroberdörster, M., Herring, A., Bendix, I., Lückemann, L., Petschulat, J., Sure, U., Keyvani, K., Hetze, S., Schedlowski, M., & Hadamitzky, M. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.108424 · Cited by 11
Таллерова, А. В., Межлумян, А. Г., Яркова, М. А., Гудашева, Т. А., & Середенин, С. Б. (2021) · Pharmaceutical Chemistry Journal · doi:10.1007/s11094-021-02397-x · Cited by 8
Tian, Y., Chen, X., Wang, Y., He, Y., Chen, C., Yu, H., Chen, Z., Ren, Y., Cheng, K., & Xie, P. (2021) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2021.12.037 · Cited by 9
Obesity and Depression: Shared Pathophysiology and Translational Implications
Huet, L., Delgado, I., Aouizerate, B., Castanon, N., & Capuron, L. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813333-0.00016-0 · Cited by 13
Self-citationInflammation and Depression: Unraveling the Complex Interplay in Inflammatory Bowel Disease
O’Donovan, A. (2014) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0000000000000292 · Cited by 9
Kodi, T., Praveen, S., Paka, S. K., Sankhe, R., Gopinathan, A., Nandakumar, K., & Kishore, A. (2024) · Advances in Pharmacological and Pharmaceutical Sciences · doi:10.1155/2024/8599268 · Cited by 8
“Te central efects of the cytokines involve the induction of sickness-like behaviour, a cluster of symptoms, which are generally observed in neurological disorders such as depression [14].”
BackgroundThuery, G., Sheridan, C., Iusan, P., Brar, G., Ledden, K., Freyne, A., Kelly, J. R., & Harkin, A. (2025) · Acta Neuropsychiatrica · doi:10.1017/neu.2025.10030 · Cited by 8
“…suggesting that IDO inhibition by these compounds contributes to a more effective tumour-reactive response by PBMCs. IDO inhibitors have previously been found to produce antidepressant-like properties in animal models of sickness behaviour (O ’ Farrell and Harkin, 2017; O ’ Connor et al ., 2009).”
Shirasath, K. R., Chaudhari, A. K., Nakhate, K. T., Goyal, S. N., & Awathale, S. N. (2025) · Phytotherapy Research · doi:10.1002/ptr.70105 · Cited by 9
Zhao, L., Yin, R., Zhang, K., Huang, J., Zheng, R., Zhu, Y., Li, G., Lei, N., Xiong, L., & Xie, Y. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05325-2 · Cited by 7
Guareschi, F., Fonseca, C., Silva, S., Pescina, S., Nicoli, S., Buttini, F., Sonvico, F., & Fortuna, A. C. (2024) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2024.106994 · Cited by 7
Microglial phagocytosis and regulatory mechanisms: Key players in the pathophysiology of depression
Wang, M., Jin, G., Duan, T., Li, R., Gao, Y., Yu, M., & Xu, Y. (2025) · Neuropharmacology · doi:10.1016/j.neuropharm.2025.110383 · Cited by 8
Tanaka, M., Anders, S. L., & Kinney, D. K. (2012) · Molecular and integrative toxicology · doi:10.1007/978-1-61779-812-2_14 · Cited by 7
Shuster-Hyman, H., Siddiqui, F., Gallagher, D., Gauthier-Fisher, A., & Librach, C. L. (2022) · Cytotherapy · doi:10.1016/j.jcyt.2022.10.014 · Cited by 7
Dai, J., Kim, H., You, Z., McCabe, M. F., Zhang, S., Wang, S., Lim, G., Chen, L. L., & Mao, J. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1084108 · Cited by 7
“previous report (O’Connor et al., 2009) in models of comorbid pain and depression.”
MethodAlzarea, S. I., Qasim, S., Afzal, M., Alsaidan, O. A., Alhassan, H. H., Alharbi, M., Alqinyah, M., & Alenazi, F. (2023) · Processes · doi:10.3390/pr11010143 · Cited by 7
Siddiqui, F., Gallagher, D., Shuster-Hyman, H., Lopez, L., Gauthier-Fisher, A., & Librach, C. L. (2023) · Journal of Inflammation · doi:10.1186/s12950-023-00340-3 · Cited by 7
“Moreover, IDO activation is shown to be crucial for depressivelike behavior in mice treated with LPS for 24 h [11, 32].”
Possible involvement of microglial P2RY12 and peripheral IL-10 in postpartum depression
Kim, H.-J., You, M., Sung, S., Rim, C., & Kwon, M. (2023) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2023.1162966 · Cited by 8
“Lipopolysaccharide (LPS) injection also induces depressive-like behaviors after sickness-like behaviors (O’connor et al., 2009).”
BackgroundAlzahrani, N. A., Bahaidrah, K. A., Mansouri, R. A., Aldhahri, R. S., El-Aziz, G. S. A., & Alghamdi, B. S. A. (2024) · Biomedicines · doi:10.3390/biomedicines12051107 · Cited by 9
Liang, Y., Yang, Y., Jie, Z., Xu, K., Xu, H., Zhang, H., & Wu, X. G. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04296-0 · Cited by 9
“In addition, inflammation activates IDO which metabolizes Tryptophan (TRP) into kynurenine (KYN) [53].”
Immune and neural response to acute social stress in adolescent humans and rodents
Gabbay, V., Ely, B. A., Vileisis, J. N., Petrovic, Z., Cicvaric, A., Asnis, G. M., Kim‐Schulze, S., & Radulović, J. (2024) · Translational Psychiatry · doi:10.1038/s41398-024-03008-5 · Cited by 9
“LPS dose was selected to induce acute systemic in fl ammation based on earlier fi ndings [50, 51].”
MethodKim, H. J., Kim, H., Choi, Y., Lee, J., Kim, D., Lee, S. K., & Park, K.-S. (2021) · Phytomedicine · doi:10.1016/j.phymed.2021.153703 · Cited by 8
Réus, G. Z., Manosso, L. M., Arent, C. O., Borba, L. A., & Abelaira, H. M. (2022) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1570159x20666220329143804 · Cited by 7
Boo, K.-J., Gonzales, E. L., Remonde, C. G., Seong, J. Y., Jeon, S. J., Park, Y., Ham, B., & Shin, C. Y. (2022) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2022.073 · Cited by 8
“To determine the antidepressant effect of hycanthone, we treated C57BL/6N mice with hycanthone for 10 days and subsequently induced depressive-like behaviors via LPS stimulation (O’Connor et al., 2009) a day before the experiment (Fig.”
MethodMyers, S., McCracken, K., Buck, D. J., Curtis, J. T., & Davis, R. L. (2023) · Journal of Inflammation · doi:10.1186/s12950-023-00328-z · Cited by 9
“Also, we observed minimal evidence of sickness behavior at 24 h post-LPS which is consistent with the findings of others that report sickness-like behavior at 6 h post-LPS is largely resolved by 24 h [46].”
ResultMcGuinness, B. W., & Harkin, A. (2015) · Current topics in neurotoxicity · doi:10.1007/978-3-319-13602-8_3 · Cited by 7
Endotoxin-induced inflammation disturbs melatonin secretion in ewe
Herman, A. P., Wojtulewicz, K., Bochenek, J., Krawczyńska, A., Antushevich, H., Pawlina, B., Zielińska-Górska, M. K., Herman, A., Romanowicz, K., & Tomaszewska-Zaremba, D. (2017) · Asian-Australasian Journal of Animal Sciences · doi:10.5713/ajas.17.0196 · Cited by 7
“It was previously found that the action of interferon-gamma (IFN)-γ and IL-1β on pinealocytes is generally mediated by microglia, whereas TNFα induces its effects by acting directly on pinealocytes because TNF receptors are expressed directly in these cells [16].”
ResultInfluentialSavitz, J. B., Ford, B. N., Kuplicki, R., Khalsa, S. S., Teague, T. K., & Paulus, M. P. (2022) · Psychopharmacology · doi:10.1007/s00213-022-06263-w · Cited by 7
“Moreover, Dantzer and colleagues demonstrated that the depressive effects of lipopolysaccharide (LPS) could be blocked with an inhibitor of indoleamine-2′3-dioxygenase (IDO) without affecting brain TRP and serotonin turnover (O'Connor et al. 2009).”
BackgroundCastanon, N., Vancassel, S., Amadieu, C., Cussotto, S., Leyrolle, Q., Lucas, C., Lefèvre, A., Emond, P., Dinel, A., & Capuron, L. (2025) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2025.106107 · Cited by 9
Self-citationDiet–Microbiome–Brain Axis and Mental Health: Biological Mechanisms and Nutritional Implications
Uţu, D., Nodiți-Cuc, A.-R., Kiș, A. M., Popovici, R. A., Pitic, D. E., Trusculescu, L.-M., Marian, D., Nan, A. G., Matin, A. S., Cîmpian, D. M., et al. (2026) · Nutrients · doi:10.3390/nu18091412 · Cited by 6
“These alterations contribute to excitotoxicity, impaired neurogenesis, and depressive-like behaviours in animal models [47,48].”
Apple cider vinegar attenuates lipopolysaccharide-induced neurobehavioral deficits in mice
Asejeje, F. O., Abiola, M. A., Ben‐Azu, B., Adeosun, A., Ighodaro, O. M., & Ajayi, A. M. (2020) · Nutrire · doi:10.1186/s41110-020-00125-1 · Cited by 7
Hong, H., Gao, M., Zhou, M., Wang, A., Hua, R., Ma, Z., Wang, Y., Xu, Y., Bai, Y., Huang, G., et al. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117304 · Cited by 7
Metadata
- Authors
- O'Connor, J. C., Lawson, M. A., André, C., Moreau, M., Lestage, J., Castanon, N., Kelley, K. W., & Dantzer, R.
- Affiliations
- University of Illinois Urbana-Champaign (US)
- Centre National de la Recherche Scientifique (FR)
- Corresponding author
- Dantzer, R
- Venue
- Molecular Psychiatry
- Published
- 2008-01-15
- Volume
- 14
- Issue
- 5
- Pages
- 511-522
- ISSN
- 1359-4184 (ISSN-L)
- 1476-5578
- PMC
- PMC2683474
- OpenAlex
- W2050508296
- Cited by
- 1,278
- References
- 56
- Citations by year
- 2026: 45 · 2025: 68 · 2024: 82 · 2023: 86 · 2022: 94 · 2021: 106 · 2020: 88 · 2019: 86 · 2018: 95 · 2017: 87 · 2016: 88 · 2015: 76 · 2014: 61 · 2013: 71 · 2012: 38
- FWCI
- 11.47
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Molecular Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- HAL (submittedVersion)
- Funders
- National Institutes of Health
- National Institute on Aging (R01AG029573)
- National Institute of Mental Health (R01MH079829, R01MH071349, R01 MH-71349)
- National Institute of Diabetes and Digestive and Kidney Diseases (T32DK059802, T32 DK59802-01)
- Topics
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Keywords
- indoleamine 2,3-dioxygenase, lipopolysaccharide, depression-like behavior, kynurenine pathway, tryptophan catabolism, minocycline, 1-methyltryptophan, L-kynurenine, kynurenine/tryptophan ratio, serotonin turnover, inflammatory cytokines, comorbid depression
- MeSH terms
- Animals, Behavior, Animal, Chromatography, High Pressure Liquid, Cytokinins, Depression, Disease Models, Animal, Dose-Response Relationship, Drug, Enzyme Activation, Enzyme Inhibitors, Gene Expression Regulation, Kynurenine, Lipopolysaccharides, Male, Mice, Inbred ICR, Minocycline, Motor Activity, Swimming, Time Factors, Tryptophan, Hindlimb Suspension, Indoleamine-Pyrrole 2,3,-Dioxygenase, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.